Heparin derivatives can interact with a variety of proteins, including those involved in cell growth, angiogenesis, and metastasis. By binding to these proteins, they can inhibit processes critical for tumor development and progression, such as the formation of new blood vessels (angiogenesis) and the spread of cancer cells to other parts of the body (metastasis).
